Skip to main content
main-content
Top

07-22-2020 | COVID-19 | News

News in brief

COVID-19 pandemic linked to increased ketoacidosis at pediatric type 1 diabetes diagnosis

Author:
Eleanor McDermid

medwireNews: Researchers have identified a marked increase in the proportion of children and adolescents who have diabetic ketoacidosis at the point of type 1 diabetes diagnosis during the COVID-19 pandemic.

Clemens Kamrath (Justus Liebig University, Giessen, Germany) and study co-authors looked at data from 532 children and adolescents who were diagnosed with type 1 diabetes between March 13 and May 13 2020 at 216 centers in Germany.

At presentation, 44.7% of these children and adolescents had diabetic ketoacidosis and 19.4% had severe ketoacidosis, the team reports in a research letter published in JAMA.

The rate of diabetic ketoacidosis was significantly higher than the corresponding rates over the same periods in the preceding 2 years, which were 24.5% in 2019 and 24.1% in 2018, giving adjusted relative risks of 1.84 and 1.85, respectively.

Likewise, the rates of severe ketoacidosis were 13.9% in 2019 and 12.3% in 2018, giving significant adjusted relative risks of 1.37 and 1.55, respectively.

The researchers found the risk for presenting with diabetic ketoacidosis during the pandemic to be particularly high among children younger than 6 years. The adjusted relative risks in this group were 2.12 to 2.75 for diabetic ketoacidosis and 1.90 to 2.06 for severe acidosis, compared with the earlier time periods.

“Underlying causes may be multifactorial and reflect reduced medical services, fear of approaching the health care system, and more complex psychosocial factors,” suggests the team.

medwireNews is an independent medical news service provided by Springer Healthcare. © 2020 Springer Healthcare part of the Springer Nature Group

22 July 2020: The coronavirus pandemic is affecting all healthcare professionals across the globe. Medicine Matters’ focus, in this difficult time, is the dissemination of the latest data to support you in your research and clinical practice, based on the scientific literature. We will update the information we provide on the site, as the data are published. However, please refer to your own professional and governmental guidelines for the latest guidance in your own country.

JAMA 2020; doi:10.1001/jama.2020.13445

Related topics

Flash glucose monitoring technology

Browse new slide sets summarizing the latest results from real-world studies.

Image Credits